These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Adult classical glioblastoma with a BRAF V600E mutation. Takahashi Y; Akahane T; Sawada T; Ikeda H; Tempaku A; Yamauchi S; Nishihara H; Tanaka S; Nitta K; Ide W; Hashimoto I; Kamada H World J Surg Oncol; 2015 Mar; 13():100. PubMed ID: 25885250 [TBL] [Abstract][Full Text] [Related]
10. Malignant transformation of diffuse astrocytoma to glioblastoma associated with newly developed BRAF V600E mutation. Kanamori M; Suzuki H; Takei H; Sonoda Y; Uenohara H; Tominaga T Brain Tumor Pathol; 2016 Jan; 33(1):50-6. PubMed ID: 26404554 [TBL] [Abstract][Full Text] [Related]
11. [Epithelioid glioblastoma with BRAF V600E mutation: a clinicopathological and molecular study]. Zheng LM; Gong J; Zou Y; Zhang MN; Yu TP; Hou J; Zhou Q; Chen N Zhonghua Bing Li Xue Za Zhi; 2021 Mar; 50(3):229-235. PubMed ID: 33677887 [No Abstract] [Full Text] [Related]
12. Epithelioid GBMs show a high percentage of BRAF V600E mutation. Kleinschmidt-DeMasters BK; Aisner DL; Birks DK; Foreman NK Am J Surg Pathol; 2013 May; 37(5):685-98. PubMed ID: 23552385 [TBL] [Abstract][Full Text] [Related]
13. A rare case of BRAF V600E-mutated epithelioid glioblastoma with a sarcomatous component. Ishikawa R; Kadota K; Hayashi T; Kimura N; Inoue K; Ibuki E; Kagawa S; Kushida Y; Okada M; Miyake K; Tamiya T; Nobusawa S; Hirato J; Haba R Pathol Int; 2020 Mar; 70(3):166-170. PubMed ID: 31903645 [TBL] [Abstract][Full Text] [Related]
14. Epithelioid glioblastoma with microglia features: potential for novel therapy. Nakagomi N; Sakamoto D; Hirose T; Takagi T; Murase M; Nakagomi T; Yoshimura S; Hirota S Brain Pathol; 2020 Nov; 30(6):1119-1133. PubMed ID: 32687679 [TBL] [Abstract][Full Text] [Related]
15. BRAF VE1 immunoreactivity patterns in epithelioid glioblastomas positive for BRAF V600E mutation. Kleinschmidt-DeMasters BK; Aisner DL; Foreman NK Am J Surg Pathol; 2015 Apr; 39(4):528-40. PubMed ID: 25581727 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of EZH2 expression, BRAF V600E mutation, and CDKN2A/B deletions in epithelioid glioblastoma and anaplastic pleomorphic xanthoastrocytoma. Wang J; Liu Z; Cui Y; Liu Y; Fang J; Xu L; He Y; Du J; Su Y; Zou W; Xu Z; Li G J Neurooncol; 2019 Aug; 144(1):137-146. PubMed ID: 31214915 [TBL] [Abstract][Full Text] [Related]
17. Cerebellar glioblastoma: a clinical series with contemporary molecular analysis. Hong B; Banan R; Christians A; Nakamura M; Lalk M; Lehmann U; Hartmann C; Krauss JK Acta Neurochir (Wien); 2018 Nov; 160(11):2237-2248. PubMed ID: 30203362 [TBL] [Abstract][Full Text] [Related]
18. The Significance of Prieto R; Barrios L; Ebrat-Mancilla E; MartÃn P; Tejerina E Int J Surg Pathol; 2024 Jun; 32(4):649-666. PubMed ID: 37743598 [TBL] [Abstract][Full Text] [Related]
19. Glioblastoma in neurofibromatosis 1 patients without IDH1, BRAF V600E, and TERT promoter mutations. Shibahara I; Sonoda Y; Suzuki H; Mayama A; Kanamori M; Saito R; Suzuki Y; Mashiyama S; Uenohara H; Watanabe M; Kumabe T; Tominaga T Brain Tumor Pathol; 2018 Jan; 35(1):10-18. PubMed ID: 29138945 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical and molecular genetic study on epithelioid glioblastoma: Series of seven cases with review of literature. Khanna G; Pathak P; Suri V; Sharma MC; Chaturvedi S; Ahuja A; Bhardwaj M; Garg A; Sarkar C; Sharma R Pathol Res Pract; 2018 May; 214(5):679-685. PubMed ID: 29615337 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]